Skip to main content

Table 2 Therapy received

From: Population-based analysis of curative therapies in stage II non-small cell lung cancer: the role of radiotherapy in medically inoperable patients

Surgery (n = 245)
Surgical procedureSub-lobar resection9 4%
Lobectomy204 83%
Pneumonectomy32 13%
ChemotherapyNone112 46%
Adjuvant126 51%
Neoadjuvant7 3%
Curative Radiotherapy (n = 132)
 RT dose≥66Gy16 12%
60-66Gy43 33%
SBRT10 8%
50-59Gy63 48%
 ChemotherapyNone98 74%
Concurrent31 24%
Sequential3 2%
Non-curative treatment (n = 158)
 Palliative radiotherapy 109 69%
 Systemic treatment* 12 8%
 Best supportive care 44 28%
  1. Values are presented as n (%)
  2. RT radiation, SBRT stereotactic body radiation therapy
  3. *7 patients received both palliative RT and systemic therapy